Table 6.

Risk of Gender-Specific Cancers in Patients Diagnosed With Schizophrenia by Follow-Up Time and Diagnosis Period

Cancer Site	O	SIR	95% CI	O	SIR	95% CI	O	SIR	95% CI	O	SIR	95% CI
Women
Follow-up time	<1 y			1–4 y			5–9 y			≥10 y
Breast	82	2.50	1.99–3.10	155	1.28	1.09–1.50	183	1.35	1.16–1.56	622	1.49	1.38–1.61
Cervix	7	1.63	0.65–3.38	21	1.40	0.86–2.14	20	1.45	0.88–2.24	36	1.26	0.88–1.74
Endometrium	22	2.77	1.73–4.20	29	1.00	0.67–1.44	35	1.12	0.78–1.56	142	1.39	1.17–1.63
All	284	2.30	2.04–2.59	465	1.03	0.94–1.13	574	1.16	1.07–1.26	1690	1.17	1.11–1.22
Diagnosis period	1965–1974			1975–1984			1985–1994			1995–2008
Breast	352	1.55	1.39–1.72	451	1.52	1.39–1.67	169	1.30	1.11–1.52	70	1.33	1.04–1.68
Cervix	23	1.06	0.67–1.60	37	1.48	1.04–2.04	17	1.57	0.92–2.53	7	1.64	0.65–3.40
Endometrium	88	1.49	1.19–1.84	93	1.29	1.04–1.58	33	1.17	0.81–1.65	14	1.23	0.67–2.06
All	1041	1.23	1.16–1.31	1292	1.21	1.14–1.28	483	1.12	1.02–1.22	197	1.16	1.00–1.33
Men
Follow-up time	<1 y			1–4 y			5–9 y			≥10 y
Prostate	35	1.41	0.98–1.96	43	0.48	0.35–0.65	59	0.60	0.45–0.77	236	0.58	0.50–0.65
All	216	1.81	1.58–2.07	310	0.72	0.64–0.80	364	0.76	0.68–0.84	1198	0.74	0.69–0.78
Diagnosis period	1965–1974			1975–1984			1985–1994			1995–2008
Prostate	146	0.65	0.55–0.77	141	0.53	0.44–0.62	61	0.65	0.50–0.83	25	0.68	0.44–1.01
All	759	0.77	0.72–0.83	865	0.76	0.71–0.81	346	0.88	0.79–0.98	118	0.81	0.67–0.97

Note: Abbreviations are explained in the first footnote to table 2.